Search Results - "STOUGAARD, ELISABETH BUUR"

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes by Stougaard, Elisabeth Buur, Winther, Signe Abitz, Amadid, Hanan, Frimodt-Møller, Marie, Persson, Frederik, Hansen, Tine Willum, Rossing, Peter

“…Background Glycocalyx lines the inner surface of the capillary endothelium. Capillaroscopy enables visualization of the sublingual capillaries and measurement…”
Get full text

Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors by Rotbain Curovic, Viktor, Stougaard, Elisabeth Buur, Hansen, Tine Willum

“…The global prevalence of chronic kidney disease (CKD) is approximately 9%. CKD is predicted to become the fifth largest global cause of death by 2040…”
Get full text

380-P: Endothelial Glycocalyx Dimensions and Cardiovascular Risk Factors in Type 1 Diabetes by STOUGAARD, ELISABETH BUUR, WINTHER, SIGNE, AMADID, HANAN, FRIMODT-MOELLER, MARIE, PERSSON, FREDERIK, HANSEN, TINE W., ROSSING, PETER

“…Background: The glycocalyx lines the inner surface of the capillary endothelium. Capillaroscopy enables visualization of the sublingual capillaries and…”
Get full text

Lower Blood Oxygen Saturation is Associated With Microvascular Complications in Individuals With Type 1 Diabetes by Laursen, Jens Christian, Mizrak, Hatice Isik, Kufaishi, Huda, Hecquet, Sofie Korsgaard, Stougaard, Elisabeth Buur, Tougaard, Ninna Hahn, Frimodt-Møller, Marie, Hansen, Tine Willum, Hansen, Christian Stevns, Rossing, Peter

“…Blood oxygen saturation (SpO2) is lower in type 1 diabetes (T1D) compared with nondiabetic controls. Hypoxia (low tissue oxygenation) is thought to be a risk…”
Get full text

406-P: Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Trial by TOUGAARD, NINNA H., FRIMODT-MOELLER, MARIE, SALMENKARI, HANNE, STOUGAARD, ELISABETH BUUR, MATTILA, ISMO, HANSEN, TINE W., LEGIDO-QUIGLEY, CRISTINA, HÖRKKÖ, SOHVI, FORSBLOM, CAROL, GROOP, PER-HENRIK, LEHTO, MARKKU, ROSSING, PETER

“…Background: Fecal calprotectin, a marker of inflammation, is increased in persons with type 1 diabetes (T1D) and kidney disease. This may be explained by a…”
Get full text

Diabetes Management During Breastfeeding in Women with Type 1 Diabetes by Ringholm, Lene, Stougaard, Elisabeth Buur, Nørgaard, Sidse Kjærhus, Damm, Peter, Mathiesen, Elisabeth R.

“…Purpose of Review To provide an update on glycemic management of type 1 diabetes during breastfeeding with focus on diet and insulin treatment to prevent…”
Get full text

396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes by STOUGAARD, ELISABETH BUUR, KRISTENSEN, PETER L., KIELGAST, URD, ANDERSEN, SR., HENRIK U., HAMID, YASMIN H., GÆDE, PETER, SØNDERGAARD, ESBEN, DØRFLINGER, GRY, FJELDBORG, KAREN K., HANSEN, KLAVS W., THOMSEN, HENRIK H., AL-IMARI, THURAYA, RØDER, MICHAEL, ROSSING, PETER, PERSSON, FREDERIK

“…Background: The indication for treatment of type 1 diabetes (T1D) with the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been withdrawn…”
Get full text